NewzThe Supreme Court of India has directed the central government to implement price caps on non-patented medicines to improve healthcare affordability. The judicial directive addresses the rising cost of essential pharmaceuticals that fall outside patent protections.
The intervention aims to curb excessive pricing practices in the domestic medical market, ensuring that standard treatments and non-proprietary drugs remain accessible to the broader population. The court's directive places pressure on regulatory authorities to enforce stricter price controls across the pharmaceutical sector.
In-depth summary · AI, neutral